The Cedars-Sinai Smidt Heart Institute Takotsubo Registry & Proteomic Study

Launched by CEDARS-SINAI MEDICAL CENTER · Apr 8, 2019

Keywords

ClinConnect Summary

The Cedars-Sinai Smidt Heart Institute is conducting a study called the Takotsubo Registry & Proteomic Study, which focuses on a heart condition known as Takotsubo cardiomyopathy. This condition can occur suddenly, often triggered by emotional or physical stress, and affects how the heart pumps blood. The researchers aim to collect information from individuals diagnosed with this condition to better understand its different types, improve how it is diagnosed, predict how often it might happen again, and develop more targeted treatments.

To participate in this study, individuals must be 18 years or older and have been diagnosed with Takotsubo cardiomyopathy by their doctor. They will need to provide their medical records for review. Participants can expect to share information about their health and may be asked to send a blood sample using a kit that will be sent to their home. This study is currently recruiting participants and is open to people of all genders within a certain age range. By joining, participants will contribute to important research that could lead to better care for others with this condition in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Have received a diagnosis of Takotsubo from their physician and consent to enroll
• • Submit full medical records needed for Takotsubo adjudication
• Exclusion Criteria:
• • Younger than 18 years
• • Unable to provide informed consent
• • Unable to provide the necessary documentation needed for screening purposes